U.S. Attorney Probes Bristol-Myers For Securities Fraud
An ongoing investigation into corporate governance issues at Bristol-Myers Squibb Co. by the Office of the U.S. Attorney for the District of New Jersey has been broadened to include a probe...To view the full article, register now.
Already a subscriber? Click here to view full article